
Shree Ganesh Biotech Reports Strong Sales Growth Amid Liquidity Challenges for Q4 2024
2025-02-04 18:32:17Shree Ganesh Biotech India has announced its financial results for the quarter ending December 2024, highlighting a significant year-on-year increase in net sales to Rs 16.39 crore. The company achieved its highest operating profit and profits before and after tax in five quarters, although liquidity challenges persist.
Read More
Shree Ganesh Biotech Hits 52-Week Low Amid Broader Agriculture Sector Decline
2025-01-27 10:35:47Shree Ganesh Biotech India, a microcap in the agriculture sector, has reached a new 52-week low amid a broader industry downturn. The company has seen a significant decline over the past year, contrasting with the overall market performance, indicating ongoing challenges and the need for strategic reassessment.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04-Apr-2025 | Source : BSEPFA
Closure of Trading Window
21-Mar-2025 | Source : BSEPFA
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
04-Feb-2025 | Source : BSEPFA
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Shree Ganesh Biotech India Ltd has announced 1:10 stock split, ex-date: 10 Feb 22
Shree Ganesh Biotech India Ltd has announced 1:1 bonus issue, ex-date: 27 Apr 22
No Rights history available